Volume 24, Number 4—April 2018
Research
Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012–2015
Table 4
Antimicrobial agent | No. susceptible isolates/no. isolates tested (%) |
p value† | ||
---|---|---|---|---|
Total (%) | Sterile site cultures, n = 173 | Urine cultures, n = 425 | ||
Any aminoglycoside‡ | 421/577 (72.9) | 123/166 (74.1) | 298/411 (72.5) | 0.70 |
Tobramycin | 308/541 (56.9) | 92/158 (58.2) | 216/383 (56.4) | 0.70 |
Amikacin | 254/416 (61.1) | 71/121 (58.7) | 183/295 (62.0) | 0.52 |
Gentamicin |
175/571 (30.7) |
49/163 (30.1) |
126/408 (30.9) |
0.85 |
Any fluoroquinolone‡ | 20/575 (3.5) | 1/164 (0.6) | 19/411 (4.6) | 0.02 |
Levofloxacin | 15/432 (3.5) | 1/120 (0.8) | 14/312 (4.5) | 0.08 |
Ciprofloxacin |
10/522 (1.9) |
1/145 (0.7) |
9/377 (2.4) |
0.30 |
Any extended-spectrum β-lactam‡ | 114/577 (19.8) | 27/165 (16.4) | 87/412 (21.1) | 0.20 |
Ceftazidime | 72/447 (16.1) | 17/129 (13.2) | 55/318 (17.3) | 0.28 |
Cefepime | 68/562 (12.1) | 18/161 (11.2) | 50/401 (12.5) | 0.67 |
Piperacillin/tazobactam |
4/113 (3.5) |
1/37 (2.7) |
3/76 (1.9) |
>0.99 |
Other | ||||
Ampicillin/sulbactam | 180/498 (36.1) | 47/146 (32.2) | 133/352 (37.8) | 0.24 |
Colistin | 114/122 (93.4) | 36/39 (92.3) | 78/83 (94.0) | 0.73 |
Trimethoprim/sulfamethoxazole | 83/483 (17.2) | 26/142 (18.3) | 57/341 (16.7) | 0.67 |
Tigecycline | 74/120 (61.7) | 27/40 (67.5) | 47/80 (58.8) | 0.35 |
*The study areas were Denver, Colorado; Atlanta, Georgia; Baltimore, Maryland; Minneapolis/Saint Paul, Minnesota, Albuquerque, New Mexico; Rochester, New York; Portland, Oregon; Nashville, Tennessee.
†The χ2 test or Fisher exact test was used to test the null hypothesis “carbapenem-nonsusceptible A. baumannii isolates antimicrobial susceptibility did not differ for sterile site vs. urine cultures.” Fisher exact test was used when >1 cell sizes was <5.
‡Includes the antimicrobial drugs listed below.
Page created: March 19, 2018
Page updated: March 19, 2018
Page reviewed: March 19, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.